About the Program
World-renowned experts in the management of prostate cancer will provide a technical update on all aspects of diagnosis and treatment of localized and advanced disease. Topics of discussion will include Genetic Markers, Prostate Pathology, mpMRI, Mapping Biopsy, Active Surveillance, Focal Therapy, Robotic Prostatectomy, Cryoablation, HIFU, Brachytherapy, IMRT/IGRT, New Approaches to Castrate Resistant Disease, Micronutrients, Morbidity Management and Testosterone Replacement Therapy.
This course is intended for urologists, radiation oncologists, medical oncologists, physicists, and other health care professionals. It will educate the registrants about advances in management of localized and advanced prostate cancer.
Prostate Cancer Symposium Course Objectives
- Identify Serum and Genetic influences on cancer aggressiveness
- Demonstrate role of mpMRI in cancer detection active surveillance and treatment
- Determine which prostate cancer patients might benefit from active surveillance rather than definitive treatment.
- Discuss the role of hormone therapy combined with chemotherapy in metastatic disease.
- Describe technical advances, including robotic radical prostatectomy; image-guided external beam radiotherapy, proton beam therapy, hypofractionated radiotherapy, computer-guided brachytherapy, related to the treatment of prostate cancer.
- Identify appropriate patients for procedures such as, brachytherapy IMRT/IGRT, proton therapy robotic and open prostatectomy, and focal therapy.
- Recognize potential benefits of chemotherapy in patients with locally advanced and hormone refractory prostate cancer.
- Describe the role of radiopharmaceuticals in advanced prostate cancer.
- Describe new agents in castrate resistant disease
- Identify patients with low testosterone and testosterone replacement in prostate cancer patients
- Discuss side effects and their management after radiotherapy and prostatectomy.
- Describe benefits of penile rehabilitation in patients treated by radiotherapy and prostatectomy
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Diversified Conference Management, Inc. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Disclosure of Conflicts of Interests
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 21.5 AMA PRA Category I Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 21.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.